Common Stock, Shares, Outstanding of LifeStance Health Group, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
LifeStance Health Group, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • LifeStance Health Group, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 388,318,000, a 1.5% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

LifeStance Health Group, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 388,318,000 +5,583,000 +1.5% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 389,000,000 +6,360,000 +1.7% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 389,077,000 +5,763,000 +1.5% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 388,826,000 +6,721,000 +1.8% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 382,735,000 +4,010,000 +1.1% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 382,640,000 +4,033,000 +1.1% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 383,314,000 +5,309,000 +1.4% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 382,105,000 +5,568,000 +1.5% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 378,725,000 +2,761,000 +0.73% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 378,607,000 +2,565,000 +0.68% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 378,005,000 +1,824,000 +0.48% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 376,537,000 +2,214,000 +0.59% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 375,964,000 +1,709,000 +0.46% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 376,042,000 +1,893,000 +0.51% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 376,181,000 +2,032,000 +0.54% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 374,323,000 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 374,255,000 +374,255,000 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 374,149,000 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 374,149,000 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q4 2020 0 31 Dec 2020 10-K 17 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.